Skip to main content
OpenTrials

Clinical trial condition

Purpura, Thrombocytopenic

Explore clinical trials studying Purpura, Thrombocytopenic. Study availability and eligibility vary by location and protocol.

340 public trials 90 recruiting studies
Refine in advanced search Browse all conditions

Purpura, Thrombocytopenic trial results

Completed

Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders

NCT00157079

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +30 more
Locations
  • Children´s Hospital Los Angeles Los Angeles, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • 1st Allergy and Clinical Research Center Englewood, Colorado, United States
  • Allergy Associates of the Palm Beaches North Palm Beach, Florida, United States
View Trial Details
Completed

Differential Diagnostic of Immune ThrombocytoPenia (ITP) and Myelodysplastic Syndrome (MDS)

NCT03469661

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +18 more
Locations
  • Complejo Hospitalario de A Coruña A Coruña, Spain
  • Hospital de Burgos Burgos, Spain
  • Hospital Universitario Insular de Gran Canaria Las Palmas de Gran Canaria, Spain
  • Hospital Ramon y Cajal Madrid, Spain
View Trial Details
Completed

Low Dose Rituximab in Thrombotic Thrombocytopenic Purpura

NCT01554514

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Cytopenia, +14 more
Locations
  • Emory University Atlanta, Georgia, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Washington University St Louis, Missouri, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details
Completed

Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases

NCT01988506

Conditions
Ankylosing Spondylitis, Ankylosis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, +90 more
Locations
  • Henri Mondor - Médecine Interne Créteil, France
  • Médecine interne - Hôpital Saint-Antoine Paris, France
  • Service de médecine vasculaire - HEGP Paris, France
  • Service d' Hépato Gastro Entérologie - Hôpital SAINT-ANTOINE Paris, Île-de-France Region, France
View Trial Details
Completed

A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj. in Primary Immune Thrombocytopenia (ITP)

NCT03164915

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Busan National University Hospital Busan, South Korea
  • Bundang Seoul National University Hospital Seongnam, South Korea
  • Samsung Medical Center Seoul, South Korea
  • Severance Hospital Seoul, South Korea
View Trial Details
Completed

Prospective Psychometric Evaluation Study of a Patient-reported Outcomes (PRO) Instrument for Congenital Thrombotic Thrombocytopenic Purpura (cTTP, Upshaw-Schulman Syndrome [USS], Hereditary Thrombotic Thrombocytopenic Purpura [hTTP]

NCT03519672

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Congenital Thrombotic Thrombocytopenic Purpura, +14 more
Locations
  • AutoCruitment Atlanta, Georgia, United States
  • Houston Methodist Research Institute Houston, Texas, United States
  • Cambridge University Hospital Cambridge, United Kingdom
  • University College London Hospital London, United Kingdom
View Trial Details
Completed

A Trial of Eltrombopag or Intravenous Immune Globulin Before Surgery for Immune Thrombocytopenia Patients

NCT01621204

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • University of Alberta Hospital Edmonton, Alberta, Canada
  • Vancouver General Hospital Vancouver, British Columbia, Canada
  • Hamilton Health Sciences Hamilton, Ontario, Canada
  • London Health Sciences Center London, Ontario, Canada
View Trial Details

Related conditions